2002
DOI: 10.1016/s0890-6238(02)00051-5
|View full text |Cite
|
Sign up to set email alerts
|

Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
114
0

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 221 publications
(120 citation statements)
references
References 16 publications
6
114
0
Order By: Relevance
“…Because of concerns that BPA alters the development of rodents exposed during gestation, several human biomonitoring studies have focused on measuring BPA in serum from pregnant women, and in plasma, serum, and tissue from umbilical cords (Ikezuki et al 2002;Kuroda et al 2003;Lee et al 2008;Padmanabhan et al 2008;Schönfelder et al 2002;Tan and Ali Mohd 2003;Todaka and Mori 2002;Yamada et al 2002) (Tables 4 and 5). Of the eight studies examining these populations, six used analytical chemistry and two used ELISA.…”
Section: Healthymentioning
confidence: 99%
See 1 more Smart Citation
“…Because of concerns that BPA alters the development of rodents exposed during gestation, several human biomonitoring studies have focused on measuring BPA in serum from pregnant women, and in plasma, serum, and tissue from umbilical cords (Ikezuki et al 2002;Kuroda et al 2003;Lee et al 2008;Padmanabhan et al 2008;Schönfelder et al 2002;Tan and Ali Mohd 2003;Todaka and Mori 2002;Yamada et al 2002) (Tables 4 and 5). Of the eight studies examining these populations, six used analytical chemistry and two used ELISA.…”
Section: Healthymentioning
confidence: 99%
“…For instance, BPA levels in blood have been associated with a variety of conditions in women, including obesity, endometrial hyperplasia, endometriosis, recurrent miscarriages, sterility, and PCOS (reviewed by Vandenberg et al 2007). Other studies detected associations between high BPA exposure and chromosomal abnormalities, including pregnancies with fetuses that had an abnormal karyotype (Yamada et al 2002), recurrent miscarriage (Sugiura-Ogasawara et al 2005), and sister chromatid exchange measured in peripheral lymphocytes (Yang et al 2006). These epidemiological studies have several limitations, including small sample sizes, insufficient information on subject selection criteria, and crosssectional designs that failed to adequately control for potential confounders (Vandenberg et al 2007), thus preventing accurate assessments regarding the potential health risks of BPA.…”
Section: Relationships Between Measured Bpa Concentrations and Diseasmentioning
confidence: 99%
“…Studies from industrialized nations such as Germany and Japan, suggest that measurable levels of BPA are found in maternal circulation. [27][28][29] Similar studies have not been undertaken with pregnant women in the United States. The only available information in the US population relates to urinary levels of BPA metabolites in the general population.…”
Section: Introductionmentioning
confidence: 99%
“…It was observed that several EDCs are able to pass through the placenta to the fetus. Many recent studies were devoted to the transmittance of EDC and assessing their content in the cord blood serum and maternal adipose tissue [13][14][15][16][17][18][19][20][21][22][23][24][25][26], showing that a fetus and once born an infant may be exposed to significantly high levels of EDC [27]. This can result in a decrease in fetal birth weight, premature birth, psychomotor retardation and altered cognitive function [28][29][30][31][32][33].…”
Section: Endocrine Disrupting Compoundsmentioning
confidence: 99%